CYTOKINETICS, INCORPORATED Repayments of Secured Debt
CYTOKINETICS, INCORPORATED (CYTK) reported Repayments of Secured Debt of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfSecuredDebt · last filed 2015-03-06
- CYTOKINETICS, INCORPORATED repayments of secured debt for the quarter ending 2012-12-31 was $0.00, a 100.00% decline year-over-year.
- CYTOKINETICS, INCORPORATED repayments of secured debt for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- CYTOKINETICS, INCORPORATED repayments of secured debt for the quarter ending 2012-06-30 was $0.00, a 100.00% decline year-over-year.
- CYTOKINETICS, INCORPORATED repayments of secured debt for the quarter ending 2012-03-31 was $152.00K, a 41.76% decline year-over-year.
- CYTOKINETICS, INCORPORATED repayments of secured debt for fiscal 2014 was $0.00.
- CYTOKINETICS, INCORPORATED repayments of secured debt for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- CYTOKINETICS, INCORPORATED repayments of secured debt for fiscal 2012 was $152.00K, a 81.75% decline from fiscal 2011.
- CYTOKINETICS, INCORPORATED repayments of secured debt for fiscal 2011 was $833.00K, a 48.45% decline from fiscal 2010.
| Period end | Repayments of Secured Debt 3 month | Repayments of Secured Debt 6 month | Repayments of Secured Debt 9 month | Repayments of Secured Debt 12 month | Repayments of Secured Debt 167 month | Repayments of Secured Debt 170 month | Repayments of Secured Debt 173 month | Repayments of Secured Debt 176 month | Repayments of Secured Debt 179 month | Repayments of Secured Debt 182 month | Repayments of Secured Debt 185 month | Repayments of Secured Debt 188 month | Repayments of Secured Debt 191 month | Repayments of Secured Debt 194 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-03-06 | |||||||||||||
| 2013-12-31 | $0.00 10-K · filed 2015-03-06 | |||||||||||||
| 2013-09-30 | $24.17M 10-Q · filed 2013-11-06 | |||||||||||||
| 2013-06-30 | $24.17M 10-Q · filed 2013-08-07 | |||||||||||||
| 2013-03-31 | $24.17M 10-Q · filed 2013-05-08 | |||||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-06 | $0.00 derived: sum of 2 quarters · filed 2015-03-06 | $0.00 derived: sum of 3 quarters · filed 2015-03-06 | $152.00K 10-K · filed 2015-03-06 | $24.17M 10-K · filed 2013-03-15 | |||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $0.00 derived: sum of 2 quarters · filed 2013-11-06 | $152.00K 10-Q · filed 2013-11-06 | $310.00K derived: sum of 4 quarters · filed 2014-03-07 | $24.17M 10-Q · filed 2012-11-07 | |||||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $152.00K 10-Q · filed 2013-08-07 | $310.00K derived: sum of 3 quarters · filed 2014-03-07 | $489.00K derived: sum of 4 quarters · filed 2014-03-07 | $24.17M 10-Q · filed 2012-08-06 | |||||||||
| 2012-03-31 | $152.00K 10-Q · filed 2013-05-08 | $310.00K derived: sum of 2 quarters · filed 2014-03-07 | $489.00K derived: sum of 3 quarters · filed 2014-03-07 | $724.00K derived: sum of 4 quarters · filed 2014-03-07 | $24.17M 10-Q · filed 2012-05-04 | |||||||||
| 2011-12-31 | $158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $337.00K derived: sum of 2 quarters · filed 2014-03-07 | $572.00K derived: sum of 3 quarters · filed 2014-03-07 | $833.00K 10-K · filed 2014-03-07 | $24.02M 10-K · filed 2012-03-13 | |||||||||
| 2011-09-30 | $179.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $414.00K derived: sum of 2 quarters · filed 2012-11-07 | $675.00K 10-Q · filed 2012-11-07 | $1.03M derived: sum of 4 quarters · filed 2013-03-15 | $23.86M 10-Q · filed 2011-11-04 | |||||||||
| 2011-06-30 | $235.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $496.00K 10-Q · filed 2012-08-06 | $848.00K derived: sum of 3 quarters · filed 2013-03-15 | $1.27M derived: sum of 4 quarters · filed 2013-03-15 | $23.68M 10-Q · filed 2011-08-04 | |||||||||
| 2011-03-31 | $261.00K 10-Q · filed 2012-05-04 | $613.00K derived: sum of 2 quarters · filed 2013-03-15 | $1.03M derived: sum of 3 quarters · filed 2013-03-15 | |||||||||||
| 2010-12-31 | $352.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $772.00K derived: sum of 2 quarters · filed 2013-03-15 | $1.62M 10-K · filed 2013-03-15 | |||||||||||
| 2010-09-30 | $420.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $1.26M 10-Q · filed 2011-11-04 | ||||||||||||
| 2010-06-30 | $844.00K 10-Q · filed 2011-08-04 | |||||||||||||
| 2009-12-31 | $2.04M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |